Subscribe to Newsletter

Business & Regulation

Business & Regulation Trends & Forecasts

Drugs to Watch in 2025: Part 2

| Stephanie Vine | 9 min read

We take a deep dive into key industry trends off the back of Clarivate’s Drugs to Watch 2025 report

Business & Regulation Business Practice

Biden’s Legacy; Trump’s Agenda: Part 2

| 7 min read

In part 2 of our roundtable discussion, thought leaders discuss what Trump could do for drug pricing and whether change is to be feared or embraced.

Business & Regulation Trends & Forecasts

Drugs to Watch in 2025: Part 1

| Stephanie Vine | 8 min read

We speak with Clarivate about their report listing eleven key drugs to watch in 2025.

Business & Regulation Business Practice

Biden’s Legacy; Trump’s Agenda: Part 1

| 10 min read

Biden pushed drug pricing reforms, whereas Trump is known for deregulation. What does this mean for pharma?

Business & Regulation Supply Chain

The UK's Radiopharma Revolution

| Juliana Maynard | 6 min read

Radiopharmaceuticals are a promising approach to cancer, but some countries are lagging behind. A collaboration hopes to change that.

Business & Regulation Profession

Sitting Down With... Moncef Slaoui

| 5 min read

The career path of Moncef Slaoui has resulted in billions of doses of lifesaving vaccines. Here he shares his story.

Business & Regulation Business Practice

Where Does All the Profit Go?

| Stephanie Vine | 2 min read

To shareholders – according to an analysis of financial reports from healthcare companies.

Business & Regulation Standards & Regulation

UK Launches Seven New Centres for Regulatory Science and Innovation

| Stephanie Vine | 3 min read

A regulatory science push in the UK includes centres for digital transformation, AI and more.

Business & Regulation Standards & Regulation

RFK Jr’s Speech Leaks: Vaccines, Autism, and Chronic Illness

| Stephanie Vine | 3 min read

Robert F Kennedy Jr’s recent speech suggests that investigations into childhood vaccines and over-medication could be on the cards.

Business & Regulation Standards & Regulation

AMF’s 2026 AMR Strategy, Revealed

| Rob Coker | 3 min read

The Access to Medicine Foundation has developed the 2026 AMR Benchmark to recognize and promote urgency in the ongoing AMR challenge.

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register